MoonLake Immunotherapeutics earnings per share and revenue

MLTX earnings per share for the last quarter are -0.12 USD whereas the estimation was -0.23 USD which accounts for 47.92% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.19 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of MLTX earnings per share and revenue dynamics.